Inhibitors of ACK1/TNK2 tyrosine kinase

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9850216
SERIAL NO

14910486

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described are cancer therapies and anti-cancer compounds. In particular, disclosed are inhibitors of Ack1 tyrosine kinase and their use in the treatment of cancer. Methods of screening for new Ack1 tyrosine kinase inhibitors are also disclosed. In specific example, compound having Formula I through IV are disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC12902 MAGNOLIA DRIVE TAMPA FL 33612-9497

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lawrence, Harshani R Tampa, US 14 37
Lawrence, Nicholas J Tampa, US 36 72
Mahajan, Kiran N Tampa, US 5 12
Mahajan, Nupam P Tampa, US 11 14

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 26, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 26, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00